Instalab
logoInstalab

BMD T-Score

The standard for catching weak bones before they break, often years before any symptom appears.
4.8 (2,345 reviews)
Physician-reviewed results
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get your X-ray
At an imaging center near you
Get results
Explained with clear next steps, no medical jargon

Should you take a BMD T-Score test?

This test is most useful if any of these apply to you.

Going Through or Past Menopause
Estrogen drops sharply at menopause and bone loss accelerates, making this the highest-yield window to baseline your bone strength.
Taking Long-Term Steroids
Oral steroids accelerate bone loss within months. If you have been on them more than three months, you need a baseline reading.
With a Family History of Fracture
A parent who broke a hip is one of the strongest predictors of your own fracture risk. Knowing your starting point lets you act early.
Healthy but Want to Stay Ahead
Bone loss is silent until something snaps. A baseline scan in your 50s gives you a trajectory to compare against for the rest of your life.

About BMD T-Score

By the time most people learn their bones are fragile, they have already broken one. The BMD (bone mineral density) T-score is how you find out years earlier, while you still have time to do something about it. It is a single number from a quick imaging scan that tells you how your bone strength compares to that of a healthy young adult at peak bone mass.

Each one-point drop in your T-score roughly doubles your fracture risk. That makes this one of the few numbers in medicine where a small move on paper translates directly into a major shift in real-world risk. Knowing your T-score gives you a baseline, a trajectory, and a target.

What This Number Actually Reflects

Bone is living tissue. Throughout your life, specialized cells dissolve old bone and lay down new bone in a constant rebuild. When that balance tips toward dissolving faster than rebuilding, bone density drops. The T-score is a snapshot of where you stand on that continuum.

The score itself is a statistical comparison. A T-score of zero means your bone density matches the average of a healthy 25 to 30 year old. A negative score means your bones are less dense than that reference. The further below zero, the thinner the bone.

The standard test that produces this number is called DXA (dual-energy X-ray absorptiometry). It uses two low-dose X-ray beams to estimate how much mineral is packed into your spine, hip, and femoral neck. The radiation dose is small, similar to a few hours of natural background exposure.

Fracture Risk

The clearest reason to know your T-score is fracture risk. Hip and spine fractures in older adults are not minor events. They reshape independence, mobility, and life expectancy. Lower T-scores make those fractures dramatically more likely.

In a study of more than 200,000 postmenopausal women, those with osteoporosis by T-score had roughly four times the fracture rate of women with normal bone density, and those with osteopenia had about 1.8 times the rate. In a Korean cohort of women at age 66, the 10-year fragility fracture rate was 31.1% in women with normal T-scores, 37.5% in those with osteopenia, and 44.3% in those with osteoporosis.

Even "normal" carries real risk. T-score is one of the strongest predictors you have, but a normal reading does not mean zero risk. Many fractures happen at T-scores above the osteoporosis cutoff, especially in people with prior fractures, falls, or other risk factors. This is why fracture risk calculators like FRAX combine T-score with age, weight, smoking, and family history.

Diabetes and Bone Quality

Type 2 diabetes is one of the few conditions where T-scores can fool you. People with diabetes tend to have higher T-scores than non-diabetics yet break bones more often. The likely reason is that diabetes damages the internal scaffolding of bone in ways the density scan cannot see.

Recent guidance suggests that a T-score of -2.0 in someone with diabetes carries roughly the same fracture risk as a T-score of -2.5 in someone without diabetes. If you have diabetes, your T-score should be interpreted with that adjustment in mind.

Mortality and Long-Term Health

Beyond fractures, low bone density tracks with broader mortality. In a large analysis of nearly 12,000 adults, osteoporosis defined by T-score was associated with higher all-cause death rates, particularly in older adults and those with lower body weight. The link is not solely about falls. Bone health reflects systemic factors like inflammation, hormonal balance, kidney function, and physical activity, which all influence longevity.

Reference Ranges

These ranges come from the WHO (World Health Organization) and the ISCD (International Society for Clinical Densitometry) and apply to central DXA measurements at the spine, hip, and femoral neck in postmenopausal women and men aged 50 and older. Different reference populations and ethnic-specific data can shift your number, so compare your results within the same lab and the same skeletal site over time.

TierT-score RangeWhat It Suggests
Normal≥ -1.0Bone density at or above the threshold for low fracture risk
Osteopenia (low bone mass)Between -1.0 and -2.5Thinner than ideal; intermediate fracture risk; many fractures occur in this range
Osteoporosis≤ -2.5Substantially weakened bones; high fracture risk; standard threshold for treatment consideration

If you have a personal history of a fragility fracture, especially of the hip or spine, you can be diagnosed with osteoporosis even if your T-score is above -2.5. The fracture itself is the diagnosis.

Why Fracture Risk Is Not Captured by T-Score Alone

A meaningful share of fragility fractures occur in people whose T-scores are above -2.5. In a registry of more than 7,000 fracture patients, 8.6% had "normal" bone density on the day they broke a bone. The reason is that T-score measures the quantity of mineral, not the architecture of the bone. Two people with the same T-score can have very different microscopic structures, and structure determines whether bone bends or snaps under load.

This is why your T-score is one input, not the whole answer. Your full picture includes prior fractures, falls history, family history, medications, and other measures of bone quality such as the trabecular bone score, which evaluates the internal scaffolding from the same DXA image.

Why One Reading Is Not Enough

Bone density changes slowly. A single T-score tells you where you stand. The trend tells you where you are headed. Two people with identical T-scores today can be on completely different trajectories, one stable and one losing bone fast. Only repeat scans reveal which path you are on.

Get a baseline scan if you are postmenopausal, over 50 with risk factors, taking long-term steroids, or simply want to know your bone trajectory. Repeat in one to two years if your initial result is normal. If you are in the osteopenia range or actively losing bone, retest in one year. If you start treatment for low bone density, expect a follow-up scan at one to two years to confirm the medication is working.

DXA scans have measurement variability, so changes smaller than roughly 3% may reflect noise rather than real bone loss or gain. Use the same lab and the same machine when possible to keep comparisons valid.

What an Abnormal Result Should Trigger

If your T-score is between -1.0 and -2.5 (osteopenia), the next step is figuring out why. Standard workup includes vitamin D, calcium, parathyroid hormone, thyroid function, kidney function, and a careful review of medications. Identify reversible causes first. Use the FRAX (Fracture Risk Assessment Tool) calculator with your T-score to estimate your 10-year fracture risk. A 10-year hip fracture risk of 3% or higher, or a major osteoporotic fracture risk of 20% or higher, generally warrants treatment even at osteopenic T-scores.

If your T-score is -2.5 or lower, or if you have had a fragility fracture, you meet the threshold for osteoporosis treatment. This is the point to involve an endocrinologist or bone specialist if your primary care physician is not actively managing your bone health. Treatment options range from oral bisphosphonates to injectable anabolic agents that actually rebuild bone.

When Results Can Be Misleading

  • Spine arthritis and calcifications: older spines often have bone spurs and calcified ligaments that artificially raise the lumbar spine T-score. If your spine looks better than your hip, your hip number is probably the more reliable read.
  • Recent contrast or nuclear medicine studies: wait at least one to two weeks after a CT with contrast or a barium study before having a DXA scan, since residual contrast in the body can distort the X-ray reading.
  • Body size and positioning: very small or very large body frames, prior hip replacement, or improper positioning during the scan can shift the result. Consistent technique at the same lab matters more than chasing a perfect number on one machine.
  • Reference population: your T-score depends on the reference data your lab uses. Studies show that switching from US to Asian-specific references can change osteoporosis prevalence in the same population from 26.6% to 10.8%. Compare your trend within the same lab rather than across labs.

What Moves This Biomarker

Evidence-backed interventions that affect your BMD T-Score level

Increase
Bisphosphonates and other osteoporosis drugs (alendronate, zoledronate, denosumab, romosozumab, teriparatide, abaloparatide)
These are the standard medical treatments when your T-score crosses into osteoporosis territory. They raise bone density and reduce fracture risk. In a randomized trial of postmenopausal women transitioning from bisphosphonate therapy, romosozumab produced significant gains in hip bone mineral density compared to teriparatide. A network meta-analysis of randomized trials found that bone-building (anabolic) treatments are more effective than bisphosphonates at preventing both clinical and vertebral fractures, regardless of baseline risk.
MedicationStrong Evidence
Decrease
Long-term systemic glucocorticoid use (prednisone and similar steroids)
Oral steroids genuinely cause bone loss by suppressing the cells that build bone and accelerating the cells that dissolve it. In children and adolescents on long-term steroid therapy for other conditions, higher cumulative glucocorticoid dose was associated with lower bone mineral density and higher vertebral fracture risk. Adults on chronic steroid therapy face the same pattern. If you are on steroids for more than three months, you should be tested and considered for protective treatment regardless of your starting T-score.
MedicationStrong Evidence
Increase
High-intensity resistance and impact training
Heavy loading is one of the few non-drug interventions that actually rebuilds bone. In the LIFTMOR randomized trial of 101 postmenopausal women with osteopenia or osteoporosis, twice-weekly supervised high-intensity resistance and impact training improved bone mineral density and physical function compared to a low-intensity home program, without adverse events. Walking and light cardio do not produce the same effect. The mechanical stress needs to be substantial enough to signal bones to thicken.
ExerciseModerate Evidence
Increase
Hormone replacement therapy with estrogen (or estrogen plus progesterone)
Estrogen is one of the strongest signals telling bone-dissolving cells to slow down. Loss of estrogen at menopause is why bone density falls so sharply for women in midlife. In a randomized trial of young women with primary ovarian insufficiency, three years of physiological transdermal estradiol restored bone mineral density. In oligo-amenorrheic athletes, transdermal estradiol over 12 months improved bone density compared to a standard oral contraceptive. Discontinuation reverses the gains; bone density does not stay protected after stopping.
MedicationModerate Evidence
Decrease
Long-acting injectable contraceptives (depot medroxyprogesterone) and GnRH agonists or antagonists
These medications suppress estrogen production, and the bone responds the same way it does at menopause: it loses density. Reviews of premenopausal women on depot medroxyprogesterone, GnRH agonists, or GnRH antagonists show consistent reductions in bone mineral density during use. If you are on one of these long-term, periodic T-score monitoring is reasonable, especially if you have other risk factors for low bone density.
MedicationModerate Evidence
Decrease
Smoking cigarettes
Smoking is consistently linked to lower bone density and higher fracture risk. In a study of nearly 25,000 Chinese adults using calcaneal quantitative ultrasound, smoking was associated with lower stiffness index and T-score values. The effect is dose-dependent and accumulates over years of exposure.
LifestyleModerate Evidence
Increase
Maintaining higher body weight (BMI in the overweight range)
Higher body weight produces higher T-scores on average and reduces hip fracture risk in many populations, but it shifts fracture risk to other sites. A meta-analysis found that obesity reduces hip fracture risk in postmenopausal women but increases ankle fracture risk. The number on your DXA scan looks better with more weight, but underlying bone quality and fall mechanics still matter, and weight loss for other health reasons should not be avoided to protect a T-score.
LifestyleModerate Evidence
Increase
Combined calcium and vitamin D supplementation
Calcium and vitamin D together produce small but real increases in bone mineral density, particularly at the pelvis. A meta-analysis of randomized trials in postmenopausal women with osteoporosis found that combined supplementation improved pelvic bone mineral density and corrected vitamin D deficiencies. The effect size is modest, and a separate meta-analysis found that calcium supplementation alone produces only small, non-progressive increases that are unlikely to meaningfully reduce fracture risk on their own.
SupplementModest Evidence
Decrease
High-dose vitamin D supplementation alone (4,000 to 10,000 IU daily)
More vitamin D is not better. In a randomized trial of 311 healthy adults given 400, 4,000, or 10,000 IU of vitamin D daily for three years, the higher doses produced lower radial bone density compared to the standard dose, with no improvement in bone strength. If your vitamin D level is in the normal range, megadosing offers no bone benefit and may cause harm.
SupplementModest Evidence

Frequently Asked Questions

References

23 studies
  1. Siris E, Miller P, Barrett-connor E, Faulkner K, Wehren L, Abbott T, Berger M, Santora a, Sherwood LMJAMA2001
  2. Baek Y, Cho SW, Jeong H, Kim JH, Hwang Y, Lange J, Shin JYEndocrinology and Metabolism2021
  3. Siris E, Adler R, Bilezikian J, Bolognese M, Dawson-hughes B, Favus M, Harris ST, Beur SJ, Khosla S, Lane NE, Lindsay R, Nana a, Orwoll E, Saag K, Silverman S, Watts NOsteoporosis International2014
  4. Kadri a, Binkley N, Daffner S, Anderson PThe Journal of Bone and Joint Surgery2022